Role of immunotherapy in gastric cancer with liver metastasis.

IF 2.6 Q3 ONCOLOGY

World journal of clinical oncology Pub Date : 2024-11-24 DOI:10.5306/wjco.v15.i11.1383

Bogdan Gafton, Stefan Morarasu, Gabriel Dimofte

引用次数: 0

Abstract

Gastric cancer continues to be a significant issue for public health, marked by its widespread occurrence and high mortality rates, even as the incidence of the disease shows a declining trend. The liver is the primary site for metastatic spread, with the peritoneum, lungs, and bones also being common targets. With the advent of biologic treatments and the introduction of immunotherapy for patients with metastatic conditions, the options to treat metastatic gastric cancer have expanded. This diversified therapeutic approach is designed to enhance patient quality of life and prolong survival, showcasing the progress in treatment modalities for individuals with gastric cancer and liver metastases.

查看原文本刊更多论文

免疫疗法在胃癌肝转移中的作用

尽管胃癌的发病率呈下降趋势，但其广泛的发病率和高死亡率仍然是公共卫生的一个重要问题。肝脏是转移扩散的主要部位，腹膜、肺部和骨骼也是常见的目标。随着生物治疗方法的出现，以及针对转移性胃癌患者的免疫疗法的引入，治疗转移性胃癌的选择范围不断扩大。这种多样化的治疗方法旨在提高患者的生活质量和延长生存期，展示了胃癌肝转移患者治疗方法的进步。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

World journal of clinical oncology ONCOLOGY-

自引率

0.00%

发文量

585

期刊介绍： The WJCO is a high-quality, peer reviewed, open-access journal. The primary task of WJCO is to rapidly publish high-quality original articles, reviews, editorials, and case reports in the field of oncology. In order to promote productive academic communication, the peer review process for the WJCO is transparent; to this end, all published manuscripts are accompanied by the anonymized reviewers’ comments as well as the authors’ responses. The primary aims of the WJCO are to improve diagnostic, therapeutic and preventive modalities and the skills of clinicians and to guide clinical practice in oncology. Scope: Art of Oncology, Biology of Neoplasia, Breast Cancer, Cancer Prevention and Control, Cancer-Related Complications, Diagnosis in Oncology, Gastrointestinal Cancer, Genetic Testing For Cancer, Gynecologic Cancer, Head and Neck Cancer, Hematologic Malignancy, Lung Cancer, Melanoma, Molecular Oncology, Neurooncology, Palliative and Supportive Care, Pediatric Oncology, Surgical Oncology, Translational Oncology, and Urologic Oncology.